{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:53:42Z","timestamp":1793757222702,"version":"4.6.1"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"\n Importance<\/jats:title>\n Mounting evidence suggests transcatheter aortic valve implantation (TAVI) as preferred treatment for patients at low to intermediate surgical risk. However, limitations in study design and statistical power raise concerns about the generalizability of individual randomized clinical trials (RCTs) comparing TAVI and surgical aortic valve replacement (SAVR) to routine clinical practice.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare 1-year outcomes of TAVI vs SAVR in patients with severe symptomatic aortic stenosis at low to intermediate surgical risk applying a 2-stage individual participant data (IPD) and aggregate meta-analyses.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n MEDLINE databases were searched for RCTs comparing TAVI and SAVR in patients with aortic stenosis until June 15, 2025.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n RCTs were selected comparing TAVI vs SAVR in patients with severe symptomatic aortic stenosis at low or intermediate surgical risk with 1-year follow-up.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n IPD were obtained from all investigator-initiated RCTs (DEDICATE, NOTION, NOTION-2, and UK TAVI) and analyzed in 1- and 2-stage IPD meta-analyses. An overall meta-analysis was performed by adding aggregate data from industry-sponsored RCTs.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary end point was all-cause death or any stroke 1 year after randomization. Secondary end points included all-cause death, any stroke, disabling stroke, cardiovascular death, rehospitalization for cardiovascular cause, myocardial infarction, new-onset atrial fibrillation, new permanent pacemaker implantation, and aortic valve reintervention.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The IPD meta-analysis included 4 RCTs comprising 2873 patients (mean [SD] age, 76.7 [5.5] years; 805 [56.1%] male) at low to intermediate surgical risk randomly assigned to TAVI (n\u2009=\u20091439) or SAVR (n\u2009=\u20091434). At 1 year, the hazard ratio (HR) for the primary end point for TAVI compared to SAVR was 0.73 (95% CI, 0.56-0.95) in the 1-stage and 0.79 (95% CI, 0.49-1.27) in the 2-stage IPD meta-analysis. In the 2-stage overall meta-analysis the HR for the primary end point was 0.76 (95% CI, 0.60-0.97).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this IPD meta-analysis of 4 RCTs, and an overall meta-analysis of 8 RCTs of patients with severe symptomatic AS at low to intermediate risk, TAVI was associated with a reduction in the 1-year incidence of all-cause death or any stroke. These findings emphasize TAVI as alternative option in patients at low to intermediate risk. Long-term follow-up is warranted to evaluate sustainability of these findings.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2025.3403","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:30:16Z","timestamp":1756571416000},"page":"1175","source":"Crossref","is-referenced-by-count":5,"title":["Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk"],"prefix":"10.1001","volume":"10","author":[{"given":"Sebastian","family":"Ludwig","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Centre for Population Health Innovation, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research Partner Site North, Hamburg\/Kiel\/L\u00fcbeck, Germany"},{"name":"Cardiovascular Research Foundation, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Klimek","sequence":"additional","affiliation":[{"name":"Cardio-CARE, Medizincampus Davos, Davos, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bay","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Centre for Population Health Innovation, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research Partner Site North, Hamburg\/Kiel\/L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Centre for Population Health Innovation, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research Partner Site North, Hamburg\/Kiel\/L\u00fcbeck, Germany"},{"name":"Cardio-CARE, Medizincampus Davos, Davos, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Granada","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hildick-Smith","sequence":"additional","affiliation":[{"name":"Sussex Cardiac Centre, Brighton and Sussex University Hospitals National Health Service Trust, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma","family":"Hudson","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Evaluation, University of Aberdeen, Aberdeen, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels H\u00f8jsgaard","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation, New York, New York"},{"name":"NewYork-Presbyterian Hospital\/Columbia University Irving Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Magnussen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Centre for Population Health Innovation, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"German Centre for Cardiovascular Research Partner Site North, Hamburg\/Kiel\/L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research Partner Site North, Hamburg\/Kiel\/L\u00fcbeck, Germany"},{"name":"Department of Cardiology, Heart Center Leipzig at Leipzig University and Leipzig Heart Science, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Gustav","family":"H\u00f8rsted Thyregod","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Wendler","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"de Backer","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Toff","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom"},{"name":"National Institute for Health Research Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Centre for Population Health Innovation, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Cardio-CARE, Medizincampus Davos, Davos, Switzerland"},{"name":"School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Pietermaritzburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Seiffert","sequence":"additional","affiliation":[{"name":"German Centre for Cardiovascular Research Partner Site North, Hamburg\/Kiel\/L\u00fcbeck, Germany"},{"name":"Department of Cardiology and Angiology, BG University Hospital Bergmannsheil, Ruhr-University Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"hoi250054r1","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000932","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"hoi250054r2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease.","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"17","key":"hoi250054r3","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMoa2400685","article-title":"Transcatheter or surgical treatment of aortic-valve stenosis.","volume":"390","author":"Blankenberg","year":"2024","journal-title":"N Engl J Med"},{"issue":"19","key":"hoi250054r4","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.2022.5776","article-title":"Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial.","volume":"327","author":"Toff","year":"2022","journal-title":"JAMA"},{"issue":"37","key":"hoi250054r5","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1093\/eurheartj\/ehae331","article-title":"Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial.","volume":"45","author":"J\u00f8rgensen","year":"2024","journal-title":"Eur Heart J"},{"issue":"17","key":"hoi250054r6","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"18","key":"hoi250054r7","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"hoi250054r8","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"14","key":"hoi250054r9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"hoi250054r10","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial.","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"hoi250054r11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"hoi250054r12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/sim.7141","article-title":"Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ.","volume":"36","author":"Burke","year":"2017","journal-title":"Stat Med"},{"issue":"24","key":"hoi250054r13","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1002\/sim.2684","article-title":"Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.","volume":"25","author":"Katsahian","year":"2006","journal-title":"Stat Med"},{"issue":"2","key":"hoi250054r14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/sim.8002","article-title":"Investigating hospital heterogeneity with a competing risks frailty model.","volume":"38","author":"Rueten-Budde","year":"2019","journal-title":"Stat Med"},{"issue":"11","key":"hoi250054r15","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models.","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"issue":"16","key":"hoi250054r16","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/sim.4264","article-title":"A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data.","volume":"30","author":"Zhang","year":"2011","journal-title":"Stat Med"},{"issue":"3","key":"hoi250054r17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/jrsm.1301","article-title":"A simple method for combining binomial counts or proportions with hazard ratios for evidence synthesis of time-to-event data.","volume":"9","author":"Watkins","year":"2018","journal-title":"Res Synth Methods"},{"issue":"7650","key":"hoi250054r19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"hoi250054r20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement.","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"hoi250054r21","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamacardio.2022.2695","article-title":"Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial.","volume":"7","author":"Van Mieghem","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"21","key":"hoi250054r22","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","article-title":"Transcatheter aortic-valve replacement in low-risk patients at five years.","volume":"389","author":"Mack","year":"2023","journal-title":"N Engl J Med"},{"issue":"15","key":"hoi250054r23","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2025.03.004","article-title":"5-Year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis.","volume":"85","author":"Forrest","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi250054r24","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaf215","article-title":"Surgical versus transcatheter treatment of aortic valve stenosis-a meta-analysis of low-risk randomized trials with completed 5-year follow-up.","volume":"67","author":"Doenst","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"issue":"30","key":"hoi250054r25","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","article-title":"Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.","volume":"42","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur Heart J"},{"issue":"13","key":"hoi250054r26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","article-title":"Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.","volume":"45","author":"Thyregod","year":"2024","journal-title":"Eur Heart J"},{"issue":"9","key":"hoi250054r27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.015896","article-title":"Pacemaker implantation after balloon- or self-expandable transcatheter aortic valve replacement in patients with aortic stenosis.","volume":"9","author":"Bisson","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"hoi250054r28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020906","article-title":"Predictors of permanent pacemaker implantation in patients undergoing transcatheter aortic valve replacement\u2014a systematic review and meta-analysis.","volume":"10","author":"Ullah","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"hoi250054r18","unstructured":"Higgins? JPT, Thomas? J, Chandler? J, . Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Accessed July 06, 2025. http:\/\/cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2838480\/jamacardiology_ludwig_2025_oi_250054_1762209206.84842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:01:21Z","timestamp":1762963281000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2838480"}},"subtitle":["An Individual Participant Data Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2025.3403","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}